Protalix BioTherapeutics, Inc. (PLX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Protalix BioTherapeutics, Inc., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -21.41x |
| P/B Ratio | 2.93x |
| P/S Ratio | 2.68x |
| Profitability | |
| Gross Margin | 47.8% |
| Operating Margin | -10.4% |
| Net Margin | -12.5% |
| EBITDA Margin | -5.6% |
| Liquidity | |
| Current Ratio | 2.51x |
| Quick Ratio | 1.54x |
| Leverage | |
| Debt/Equity | 0.17x |
YoY = year-over-year change. Source: FMP..